Verdi Cancer and Research Center of Texas

Verdi Cancer and Research Center of Texas was a Dallas-area community oncology practice and clinical research site launched by Verdi Oncology in 2019. The center provided medical oncology care and was positioned to offer early phase oncology clinical trials to patients in the greater Dallas-Fort Worth market. It was led at launch by Dr. Jivesh Sharma and Dr. Amy Cripps and operated as part of Verdi Oncology’s physician-partnership model. Available evidence indicates the Texas center later closed, with a closure announcement reported in September 2023. The entity appears to have functioned primarily as a care delivery and research center rather than a drug-development biotech company with an internal therapeutic pipeline.